Latest News

Markus Müschen, MD, PhD, was selected by the Harrington Discovery Institute as a recipient of its 2026 Scholar-Innovator Award. The scholar awards support breakthrough new treatments for common and rare diseases, including cardiovascular, inflammatory, hematologic, and oncologic disease, using small molecule, biologic, cell-based, and genetic therapies.

Stem cells have reshaped modern biology. At Yale School of Medicine, researchers are uncovering how they function and how to harness them for human health.

Researchers in the Vascular Biology and Therapeutics Program are working to address chronic inflammation, heart disease, and more.

Advances in single-cell, molecular, and genetic techniques drive biomedical innovation, and YSM researchers are expanding what’s possible.

Researchers are uncovering the fundamental rules of immunology. It’s enabling them to better treat disease—and even predict it before it strikes.

Researchers investigate blocking the IL-4 signaling axis to stop melanoma from metastasizing to the brain.

A team of Yale researchers believes the key to stopping melanoma from spreading to the brain lies in the brain's own immune system, not within the tumor.

On Tuesday, May 12, 2026, members of the Skin and Kidney Cancer Program hosted an educational symposium for patients and caregivers focused on topics related to the care of melanoma.

Each spring, the Graduate School of Arts and Sciences recognizes professors from each of four divisions for their advising and mentoring of Yale students.